quantitative assay of the active drugs sulfamethoxazole and trimethoprim in pharmaceutical dosage forms.
Introduction
Sulfonamide-trimethoprim combinations of drugs are ex tensively used as antibacterial and therapeutic agents for uri nary tract infections (1) . Co-trimoxazole represents a mixture of five parts of sulfamethoxazole and one part of trimethoprim.
The optimization of solvent systems using thin-layer chro matographic (TLC) separation and the influence of ion-pair reagents (2) or different modifiers (3, 4) on the retention be havior of numerous sulfonamides in normal or reversed-phase TLC, were investigated.
TLC-densitometric methods were used for the determination of other sulfonamides, such as a sulfametrol-trimethoprim combination (5) and sulfanilamide or sulfafurazole in different dosage forms (6) . TLC separation of sulfamethoxazole and trimethoprim with subsequent densitometric measurements was described using the single standard method, but data were missing for densitometric linearity and precision of the method (7) (8) (9) (10) . Using different scanning modes (11) or a different cal ibration function (12) , investigators performed a TLC-highperformance TLC (HPTLC) densitometric determination for a diluting the stock solution so that solutions were furnished with final concentrations of 2,1.5,1, 0.8, and 0.5 mg/mL sul famethoxazole and 0.4,0.3,0.2,0.16, and 0.1 mg/mL trimetho prim. These levels represented 62.5-250% of the labeled amounts of sulfamethoxazole and trimethoprim in the drug substances and tablets. A stock solution containing 1 mg/mL of sulfanilamide and 0.1 mg/mL of sulfanilic acid was prepared in a mixture of chloroform-methanol (1:1, v/v), and 0.15 mL of a strong (25%) am monia solution was added. For an assay of sulfanilamide and sulfanilic acid, calibration curves were prepared by diluting the stock solution so that solutions were furnished with final concentrations of 0.5,0.3,0.1,0.05, and 0.025 μg/μL sulfanil amide and sulfanilic acid, and 1 μL of the diluted solutions was applied to the TLC plates. The 25-500 ng per spot value represented 31.25-250% of both USP limits of 0.2% (w/w) of an impurity in a sulfamethoxazole drug substance and 0.3% or 0.5% (w/w) of a sulfanilic acid or sulfanilamide impurity, re spectively, in the co-trimoxazole tablets.
For an actual assay of sulfanilic acid and sulfanilamide in a sulfamethoxazole drug substance and in co-trimoxazole dosage forms, a solution containing approximately 40 mg/mL of a sul famethoxazole drug substance in a mixture of chloroformmethanol (1:1, v/v) was prepared, and 1 μL was applied to the TLC plate for determination of the sulfanilic acid and sulfanil amide content. The 40-mg/mL solutions were further diluted to approximately 80 μg/mL, and 1 μL was applied to the plate for determination of the sulfamethoxazole-trimethoprim content.
Chromatography
TLC was performed on 20-× 10-mm plates coated with a 250-μm layer of silica gel 60 (Merck). Samples and standards were applied to the plates by means of a Nanomat III (Camag). The plates were developed with chloroform-w-heptane-ethanol (9:9:9, v/v/v) to a distance of 90 mm. Each plate could accom modate 14 sample spots and 5 standards. Scanning densitometry was performed with a Scanner II densitometer (Camag) coupled to an IBM PC with CATS software (V3.15) using absorbance/reflectance mode. The scanning wavelength was 260 nm.
Results and Discussion

Chromatographic separation
Separation of sulfamethoxazole, sulfanilamide, sulfanilic acid, and trimethoprim was accomplished by using neutral, acidic, or basic mobile phases; it was necessary that the mobile phases contained alcohol(s) as modifiers. The dependence of the concentration of alcohols and the polarity of the alcoholic frac tion in the mobile phase and the polarity of the mobile phases on retention of sulfamethoxazole, sulfanilamide, and sulfanilic acid was investigated.
The R f values obtained were converted into R M values using the equation R M = log (1 -R f )/R f . The relationship between R M and the mobile phase composition was expressed by the equa tion R M = R M° -m log C (%), where R M° is equal to constant extrapolated values obtained at C = 1% (alcohol) and m is the slope of the linear plot. The polarity of the alcohol fraction in the mobile phase was calculated using the expression Ρ = P n χ f n , where P n is the solvent strength parameter and φ η is part of the component.
A correlation was observed between R M values and the con- centration (36-42%) or polarity (0.17-0.25) of an alcoholic fraction in mobile phases containing binary mixtures (n-butanol-methanol, n-pentanol-methanol), ternary mixtures (npentanol-n-butanol-n-methanol), or 4% of a strong ammo nium solution in 1,2-dichloroethane as a diluent (Table I ). The slopes of plots log C (% alcohol) or log Ρ (alcohol fraction) versus R M were found to correlate strongly with the pK a of sul- famethoxazole
The R M values of sulfa compounds with lower pK a values were strongly influenced by the content and polarity of the alcoholic fraction of the mobile phase. Sulfanilic acid exhibited no mobility in the eluent containing less than 30% of the alcoholic fraction.
The mobile phase containing 15-18% formic acid or glacial acetic acid and a 30-60% fraction of alcohol (ethanol, n-butanol, t-butanol, or n-pentanol) in diisopropyl ether or methyl ethyl ketone as a diluent accomplished the separation of all compo nents of the mixture. The R M values of sul famethoxazole, sulfanilamide, and sulfanilic acid were more affected by the polarity of the mobile phase than by the polarity of the alcoholic fraction or its concentrations. R u values versus Ρ of the mobile phase corre lated; the obtained correlation coefficients for sulfamethoxazole and sulfanilamide (r = 0.993 and 0.994, respectively) were some what higher than for sulfanilic acid (r = 0.830) ( Table I) .
Quantitative assay
During the development of the quantita tive assay, two solvent mixtures were evalu ated as mobile phases: chloroform-n-heptane-ethanol (3:3:3, v/v/v) and n-butanolmethyl ethyl ketone-water-acetic acid (5:1:1:1.5, v/v/v/v). Both selected mixtures gave an excellent separation with minimum tailing. Migration distances of sulfamethox azole, sulfanilamide, trimethoprim, and sul fanilic acid were 67.05 mm ± 0.08,52.5 mm ± 0.16, 33.6 mm ± 0.13, and 18.12 mm ± 0.08, respectively, in the chloroform-n-heptane-ethanol mixture and 83 mm ± 0.1,79.1 mm ± 0.15,52.7 mm ± 0.16, and 42.7 mm ± 0.17, respectively, in the n-butanol-methyl ethyl ketone-water-acetic acid mixture.
A typical TLC chromatogram of the separa tion of sulfamethoxazole, trimethoprim, and impurities of sulfanilamide and sulfanilic acid is shown in Figure 1 . For accurate densito metric reading, the migration distances of sep arated substances are required to be between 30 and 70 mm. Even though sulfanilic acid has a lower migration distance in the chloroform-n-heptane-ethanol mixture, the results of its comparable quantitative assay using both mixtures greatly agreed. Therefore, the chloroform-n-heptane-ethanol mixture has been further used for the simultaneous determina tion of active drugs and impurities.
The content of the active drugs sulfa methoxazole and trimethoprim in dosage forms was previously analyzed by using the single standard method (7-10), linear regression (11), and log/log linear re gression (12) . Because the amount of possible degradation prod ucts, sulfanilamide, and sulfanilic acid in drug substances and dosage forms is usually unpredictable, the calibration function has to be constructed for a wider range of concentrations; sul fanilamide and sulfanilic acid were tested over the range 50-900 ng per spot. The best fit for the calibration lines was found when the calibration data were analyzed using a second-degree polynomial regression. The nonlinear polynomial function de scribed by the equation R= A 0 + A 1 C+A 2 C 2 can be used in quan titative TLC without disturbing the error distribution (14) .
The calibration functions of sulfamethoxazole and trimetho prim were constructed for the concentration ratios 500-2500 and 100-500 ng per spot, respectively. The calibration curves (peak area versus the amount of substance applied) are shown in Figure 2 . The standard deviations of calibration curves for sulfamethoxazole, trimethoprim, sulfanilamide, and sulfanilic acid were 1.7%, 2.1%, 2.3%, and 1.2%, respectively.
Because they used HPTLC, Tammilehto (12) and Datta and Das (11) obtained significantly lower concentrations of sul famethoxazole and trimethoprim; log/log linear regression and linear regression were used for applied amounts of 20-160 and 250-1000 ng per spot, respectively, for both substances.
The limit of detection (LOD) and the limit of quantitation (LOQ) were determined by fitting the interday, back-calculated standard deviations of each calibration standard. The y-inter cept was then equal to SD 0 (the estimated standard deviation at a concentration of zero). The LOD was defined as 3SD 0 , and the LOQ was defined as 10SD 0 . The LODs for sulfanilamide and sul fanilic acid were found to be 4.5 and 4.1 ng/μL, respectively (equivalent to impurity levels of 0.01%), and the LOQs were 13.5 and 12.4 ng/μL, respectively (equivalent to impurity levels of 0.03%). The LOQs for sulfamethoxazole and trimethoprim were found to be 19 and 16 ng/μL, respectively.
The repeatability of the analytical system was determined by using two samples of co-trimosul found to contain 0.22 and 0.53% of sulfanilamide and 0.19 and 0.28% of sulfanilic acid; five replicate applications of each sample gave relative standard de viations (RSDs) of 0.62 and 1.5% for sulfanilamide and 2.2 and 1.8% for sulfanilic acid, respectively. The repeatability of the sul famethoxazole-trimethoprim assay, using concentrations of 800 and 120 ng/μL, is shown by RSDs of 1.82 and 1.79%, respectively.
The accuracy of the densitometric method was proved by a determination of sulfamethoxazole and trimethoprim from the laboratory-made tablet excipient mixture spiked with 400 mg sulfamethoxazole and 80 mg trimethoprim; recoveries were 102.8 and 100.24%, respectively.
A solution containing Co-trimosul with a previously deter mined amount of sulfanilamide and sulfanilic acid was spiked with aliquots of the impurity solution at two concentrations of sulfanilamide, 0.08 and 0.2 mg/mL (equivalent to 0.2 and 0.5%), and at two concentrations of sulfanilic acid, 0.08 and 0.12 mg/mL (equivalent to 0.2 and 0.3%). Recoveries obtained were 105.5 and 103.5% for sulfanilamide, respectively, and 97.12 and 98.08% for sulfanilic acid, respectively.
The method was used to screen the raw material and dosage forms for impurities (Table II) . The results obtained for sul fanilamide (0.06% for the raw material and 0.056% for dosage forms) meet the requirements of the USP XXIII, which are not to exceed 0.2%. There was no trace of impurities of sulfanilic acid detected in the raw material and dosage forms. With regard to the label declaration, the recovery values for sulfamethoxa zole and trimethoprim in the raw material and dosage forms were very high. The values of the RSDs obtained for the raw ma terial (1.5-1.7%) and dosage forms (1.8-2.2%) confirm the ac curacy and reproducibility of the method.
Conclusion
The described quantitative densitometric method is simple, rapid, and sufficiently accurate to determine trace impurities in pharmaceutical preparations. 
